AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
AbCellera Biologics Inc. - Common Shares (ABCL)
Company Research
Source: Yahoo! Finance
Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon. Thank you for attending the AbCellera Biologics, Inc. FY 2023 earnings result and business update call. My name is Matt, and I'll be your moderator for today's call. All lines will be muted during the presentation portion of the call and an opportunity for questions and answers at the end. [Operator instructions] I would now like to pass the conference over to our host, Tryn Stimart, chief legal and compliance officer with AbCellera. Tryn, please go ahead. Tryn Stimart Chief Legal and Compliance Officer Thank you. Good morning, good afternoon, and good evening to everyone listening around the world. Thank you for joining us for AbCellera's full year 2023 earnings call. I'm Tryn Stimart, AbCellera's chief legal and compliance officer. Joining me on today's call are Dr. Carl Hansen, AbCellera's president and chief executive officer; and Andrew Booth, AbCellera chief financial officer. Dur
Show less
Read more
Impact Snapshot
Event Time:
ABCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABCL alerts
High impacting AbCellera Biologics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ABCL
News
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies [Yahoo! Finance]Yahoo! Finance
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech CompaniesBusiness Wire
- Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]Yahoo! Finance
- Sky bridge to connect new state-of-the-art research facility to Vancouver's St. Paul's hospital [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 [Yahoo! Finance]Yahoo! Finance
ABCL
Earnings
- 2/20/24 - Miss
ABCL
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- 4/29/24 - Form DEF
- ABCL's page on the SEC website